AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Search Results for: "Food and Drug Administration"

FDA Launches Campaign that Affirms LGBT Young Adults’ Freedom to Be, Tobacco Free

FDAThisFreeLife - cropped May 2016

Last week, I had the privilege of participating in the launch of “This Free Life,” the Food and Drug Administration’s (FDA) new anti-smoking campaign for lesbian, gay, bisexual and transgender (LGBT) young adults. This is FDA’s first-ever national campaign designed to prevent and reduce tobacco use among LGBT young adults (ages 18-24) who are occasional…

FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4

FDA

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Hepatitis C is a viral disease that causes inflammation of the liver that can lead to diminished liver function or liver failure….

FDA updates blood donor deferral policy to reflect the most current scientific evidence and continue to ensure the safety of the U.S. blood supply

FDA

Today, the U.S. Food and Drug Administration issued final guidance outlining updated blood donor deferral recommendations to reflect the most current scientific evidence and to help ensure continued safety of the blood supply by reducing the risk of human immunodeficiency virus (HIV) transmission by blood and blood products. “The FDA’s responsibility is to maintain a…

FDA approves new treatment for HIV

FDA

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living…

Hepatitis C in Corrections – A New Resource for Incarcerated People

Rich Feffer, Correctional Health Programs Manager, Hepatitis Education Project

A disproportionate number of people with hepatitis C (HCV) in the U.S. are or have been inmates in jails and prisons. Correctional settings therefore present significant opportunities to provide hepatitis prevention, testing, care, and treatment interventions. To help incarcerated people understand HCV, the National Hepatitis Corrections Network (NHCN)  has introduced a new resource to assist…

HHS World Hepatitis Day Observance Showcased Progress & Collaboration

CK7sSrjUsAAf2u5

On July 28, the U.S. Department of Health and Human Services (HHS) hosted the fifth annual observance of World Hepatitis Day to continue raising awareness of the burden of viral hepatitis both here in the U.S. and around the world. Globally, viral hepatitis affects 400 million people and kills over 1.4 million people annually , and…

FDA Reaches Out to Minorities During Hepatitis Awareness Month

FDA

Did you know that millions of Americans (mostly baby boomers) are living with chronic Hepatitis and up to 2/3 may not even know they are infected? Annually, in May, the public health community commemorates “Hepatitis Awareness Month” to bring attention to this disease, its symptoms, testing, and treatment options. This year, we are working with…

FDA Invites Comments on Proposal to Revise Lifetime Deferral on Blood Donation by Gay Men

FDA

In a Federal Register notice published Friday, May 15, 2015, the Food and Drug Administration (FDA) is inviting public comments on the following draft recommendations: Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products [PDF 135KB]. This draft guidance, to establishments that collect blood or blood components, proposes…